NCT02298920View on ClinicalTrials.gov

AZD0914 Phase 1 ADME Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Healthy
Interventions
DRUG

AZD0914

Radiolabelled AZD0914 for study of absorption, disposition, metabolism, and excretion in healthy volunteers.

Trial Locations (2)

53704

Covance Clinical Research Unit, Madison

Unknown

Research Site, Madison

Sponsors
All Listed Sponsors
lead

Entasis Therapeutics

INDUSTRY

NCT02298920 - AZD0914 Phase 1 ADME Study in Healthy Volunteers | Biotech Hunter | Biotech Hunter